| PERIOD ENDING | 26-Oct-08 | 28-Oct-07 | 29-Oct-06 | | Total Revenue | 8,129,240 | 9,734,856 | 9,167,014 | | Cost of Revenue | 4,686,412 | 5,242,413 | 4,875,212 | | | Gross Profit | 3,442,828 | 4,492,443 | 4,291,802 | | | Operating Expenses | | Research Development | 1,104,122 | 1,142,073 | 1,152,326 | | Selling General and Administrative | 965,164 | 952,443 | 906,742 | | Non Recurring | 18,111 | 26,421 | 212,113 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,355,431 | 2,371,506 | 2,020,621 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 73,793 | 136,149 | 185,295 | | Earnings Before Interest And Taxes | 1,429,224 | 2,478,284 | 2,203,067 | | Interest Expense | 20,506 | 38,631 | 36,096 | | Income Before Tax | 1,408,718 | 2,439,653 | 2,166,971 | | Income Tax Expense | 447,972 | 729,457 | 650,308 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 960,746 | 1,710,196 | 1,516,663 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 960,746 | 1,710,196 | 1,516,663 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $960,746 | $1,710,196 | $1,516,663 |
|
1.48% Nasdaq 
Income Statement
